Clinical Trial Update: A Pilot Study for the Evaluation of Minocycline as a Microglia Inhibitor in the Treatment of Diabetic Macular Edema [Phase 1, Phase 2]

View source ↗

Summary

A pilot Phase 1/2 study evaluated minocycline as a microglia inhibitor for diabetic macular edema; the trial has completed and results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Minocycline (minocycline)

Snippet

Sponsor: National Eye Institute (NEI) | Conditions: Diabetic Macular Edema | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2012-09-06